"The infrastructure and plants are completely separate for both the products and we will be producing both independent of each other," Biological E#39;s managing director Mahima Datla said in a text message, declining to give any timeline or other details.India#39;s Biological E. to produce Johnson Johnson COVID-19 vaccine
"The infrastructure and plants are completely separate for both the products and we will be producing both independent of each other," Biological E#39;s managing director Mahima Datla said in a text message, declining to give any timeline or other details.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment